Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.71 USD
-0.82%
Market Closed
Updated:
Apr 24, 2024
Abbott Laboratories
Cash Paid for Dividends
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Cash Paid for Dividends Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash Paid for Dividends
-$3.6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-14%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash Paid for Dividends
-$1.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash Paid for Dividends
-$28m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash Paid for Dividends
-$1.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's Cash Paid for Dividends?
Cash Paid for Dividends
-3.6B
USD
-3.6B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Cash Paid for Dividends amounts to -3.6B USD.
What is Abbott Laboratories's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 10Y
-14%
-14%
Over the last year, the Cash Paid for Dividends growth was -6%. The average annual Cash Paid for Dividends growth rates for Abbott Laboratories have been -9% over the past three years , -12% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
